Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$83.4M
-10.9% from 2023
Prescriptions
106K
$783.65 per claim
Patients
20K
14,415 prescribers
Total spending, 2024
$83.4M
$4,123.38 per patient
Medicare prescription drug plans paid $83.4M for Jentadueto in 2024, for 106,424 prescriptions and refills to 20,224 patients (down 10.9% from 2023). The average cost per claim was $783.65.
Puerto Rico had the highest Medicare cost for Jentadueto in 2024: $21.4M for 31,491 claims, followed by New York ($14.1M).
Stella Ilyayeva, internal medicine in Rego Park, NY, had the highest Medicare cost for Jentadueto in 2024: 597 claims costing $373K.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Stella Ilyayeva Rego Park, NY | Internal Medicine | 597 | 84 | $373K |
| Guireida Rivera Colon Juana Diaz, PR | Endocrinology | 351 | 58 | $241K |
| Baltazar Rodriguez Cruz IV |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 16,053 | 110,990 | 21,681 | $94.5M |
| 2023 | 15,215 | 103,691 | 20,679 | $93.6M |
| 2024 | 14,415 | 106,424 | 20,224 | $83.4M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| General Practice |
| 411 |
| 69 |
| $222K |
| 1710074026 | Internal Medicine | 244 | 49 | $208K |
| Alejandra N Santiago Ponce, PR | Endocrinology | 354 | 80 | $207K |
| Henrik Khatchatourian Glendale, CA | General Practice | 391 | 39 | $201K |
| Armine Nazaryan Glendale, CA | General Practice | 371 | 39 | $192K |
| Matin Sharafatkhah Brooklyn, NY | Endocrinology | 304 | 37 | $170K |
| Enrique J Griego McAllen, TX | Family Practice | 156 | 42 | $158K |
| Samayra Miranda Rodriguez Dorado, PR | Endocrinology | 223 | 51 | $151K |
| Lorenzo E Ross Rivera Guayama, PR | General Practice | 226 | 36 | $142K |
| Tri M Pham Modesto, CA | Internal Medicine | 117 | 40 | $140K |
| Luis E Torres Ponce, PR | General Practice | 125 | 41 | $139K |
| Norbert Correa Sardina Bayamon, PR | Internal Medicine | 133 | 32 | $138K |
| Manuel Alegre-Hernandez San Juan, PR | Endocrinology | 130 | 31 | $135K |
| Garbis Apelian Van Nuys, CA | Family Practice | 245 | 24 | $134K |
| Francisco J Nadal Colon Ponce, PR | Endocrinology | 149 | 37 | $133K |
| Victor M Simons Canovanas, PR | General Practice | 238 | 41 | $132K |
| Cesar H Trabanco Ponce, PR | Endocrinology | 204 | 41 | $131K |
| Razmik Ohanjanian Glendale, CA | Internal Medicine | 239 | 32 | $130K |
| Luis A Paz Reyes Vega Baja, PR | General Practice | 112 | 31 | $116K |
| Sheila Mercado Manati, PR | Endocrinology | 174 | 36 | $110K |
| Rafael Rodriguez Jackson Heights, NY | Internal Medicine | 96 | 27 | $106K |
| Paula V Jeffs-Gonzalez Trujillo Alto, PR | Endocrinology | 180 | 38 | $103K |
| Tsovinar Tekkelian Glendale, CA | Internal Medicine | 198 | 19 | $100K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Boehringer Ing. | 106,443 | $83.4M |